Skip to main content
Log in

Fibrositis (Fibromyalgia)

A Common Non-Entity?

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The literature on fibrositis (fibromyalgia), which originated in the early years of the last century in the UK and proliferated there in the first half of this century, has since diminished there in the last 30 years or so, but has increased in Canada and the US. Criteria suggested for diagnosis have created a syndrome with no diagnostic tests, serological or radiological signs, arid no truly objective physical signs, but with predictable tender spots on pressure. The syndrome is largely, but not completely, confined to females, mostly of middle age; the symptoms include widespread aching of more than 3 months’ duration, disturbed sleep, morning fatigue and stiffness, a failure to respond satisfactorily to any one form of therapy and a tendency to persist over long periods, but without permanent tissue changes. Features of psychological disturbance are present in many patients but not in all or even the majority. Definition of the condition as a disorder of pain modulation — a pain amplification syndrome — would seem to fit the facts best. Most would agree that an abnormal response to stress is an important factor in the appearance of the syndrome, as other stress related disorders, such as the irritable bowel syndrome and tension headaches, may coexist. Response to therapy, whether physical or pharmacological, is on the whole unsatisfactory.

This type of patient has been well recognised in hospital clinic and general practice for many years. No signs of any arthritic or rheumatic disease are present and the diffuse pains complained of do not appear to be based on underlying organic disease, although emotional and psychic states (‘attitudes of mind’ rather than psychiatric disorders) probably play a major part in many cases.

Osteoarthritic or other chronic lesions may in some cases cause pain to be referred to muscles elsewhere in body and limb, and a lowered pain tolerance from different causes may magnify the symptoms, but it is probable that different factors operate in different cases and the clinical picture is not based on any single underlying pathological or psychiatric state.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ahles TA, Yunus MB, Riley SD, et al. Psychological factors associated with primary fibromyalgia syndromes. Arthritis and Rheumatism 27: 1101–1106, 1984

    Article  PubMed  CAS  Google Scholar 

  • Balfour W. Observations with cases illustrative of a new, simple and expeditious mode of curing rheumatism and strains, J & C Muirhead, Edinburgh, 1816

  • Behan PO, Behan WMH, Bell EP. The post-viral fatigue syndrome: an analysis of the findings in 50 cases. Journal of Infection 4: 211–222, 1985

    Article  Google Scholar 

  • Bennett RM. Fibrositis: evolution of an enigma. Journal of Rheumatology 13: 676–678, 1986a

    PubMed  CAS  Google Scholar 

  • Bennett RM. Current issues concerning management of the fibrositis/fibromyalgia syndrome. American Journal of Medicine 81 (Suppl. 3A): 15–18, 1986b

    Article  PubMed  CAS  Google Scholar 

  • Benytsson A, Henriksson K-G, Jorfeldt L, Kågedal B, Lennmarken C, et al. Primary fibromyalgia. Scandinavian Journal of Rheumatology 15: 340–347, 1986

    Article  Google Scholar 

  • Calabro JJ. Fibromyalgia (fibrositis) in children. American Journal of Medicine 81 (Suppl. 3A): 57–59, 1986

    Article  PubMed  CAS  Google Scholar 

  • Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM. Clinical characteristics of fibrositis: a ‘blinded’ controlled study of symptoms and tender points. Arthritis and Rheumatism 26: 817–824, 1983

    Article  PubMed  CAS  Google Scholar 

  • Campbell SM, Gatter RA, Clark S, Bennett RM. A double blind study of cyclobenzaprine versus placebo in patients with fibrositis. Abstract D3. Arthritis and Rheumatism 27 (Suppl.): 576, 1984

    Google Scholar 

  • Caro XJ. Immunofluorescent detection of IgG at the dermal-epidermal junction in patients with apparent primary fibrositis syndrome. Arthritis and Rheumatism 27: 1174–1179, 1984

    Article  PubMed  CAS  Google Scholar 

  • Carrette S, McCain GA, Bell DA. A double blind study of amitriptyline versus placebo in patients with primary fibrositis (Abstract). Arthritis and Rheumatism 540: 158, 1985

    Google Scholar 

  • Clark S, Campbell SM, Forehand ME, et al. Clinical characteristics of fibrositis. II. A blinded controlled study using standard psychological tests. Arthritis and Rheumatism 28: 132–137, 1985

    Article  PubMed  CAS  Google Scholar 

  • Clark S, Tindall E, Bennett RM. A double-blind crossover trial of prednisone versus placebo in the treatment of fibrositis. Journal of Rheumatology 12: 980–983, 1985

    PubMed  CAS  Google Scholar 

  • Copeman WSC, Ackerman WL. ’Fibrositis’ of the back. Quarterly Journal of Medicine NS 13 (OS 37): 37–51, 1944

  • Dinerman H, Felson D, Goldenberg D. A randomised clinical trial of naproxen and amitriptyline in primary fibromyalgia (Abstract). Arthritis and Rheumatism 540: 159, 1985

    Google Scholar 

  • Dinerman H, Goldenberg DL, Felson DT. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud’s phenomenon, Sicca syndrome, ANA low complement and Ig deposition at the dermo-epidermal junction. Journal of Rheumatology 13: 368–373, 1986

    PubMed  CAS  Google Scholar 

  • Ellman P, Savage OA, Wittkower E, Rodger TF. Fibrositis. Annals of the Rheumatic Diseases 3: 56–76, 1942

    Article  PubMed  CAS  Google Scholar 

  • Felson DT, Goldenberg DL. The natural history of fibromyalgia. Arthritis and Rheumatism 29: 1522–1526, 1986

    Article  PubMed  CAS  Google Scholar 

  • Gatter RA. Pharmacotherapeutics in fibrositis. American Journal of Medicine 81 (Suppl. 3A): 63–66, 1986

    Article  PubMed  CAS  Google Scholar 

  • Goldenberg DL. Psychological studies in fibrositis. American Journal of Medicine 81 (Suppl. 3A): 67–70, 1986

    Article  PubMed  CAS  Google Scholar 

  • Gowers WR. Lumbago: its lesions and analogues. British Medical Journal 1: 117–121, 1904

    Article  PubMed  CAS  Google Scholar 

  • Hadler NM. A critical reappraisal of the fibrositis concept. American Journal of Medicine 81 (Suppl. 3A): 26–30, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hart FD. Occasional review: pain as an old friend. British Medical Journal 1: 1405–1407, 1979

    Article  PubMed  CAS  Google Scholar 

  • Hart FD. Practical problems in rheumatology, p. 135, Martin Dunitz, London, 1983

  • Henderson DA, Shelokov A. Epidemic neuromyasthenia; clinical syndrome? New England Journal of Medicine 260: 814–818, 1959

    Article  PubMed  CAS  Google Scholar 

  • Kalyan-Raman UP, Kalyan-Raman K, Yunus MB, Masi AT. Muscle pathology in primary fibromyalgia syndrome. Journal of Rheumatology 11: 808–814, 1984

    PubMed  CAS  Google Scholar 

  • Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scandinavian Journal of Rheumatology 15: 165–173, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lynn B, Kellgren JH. Pain. In Scott JT (Ed.) Copeman’s textbook of the rheumatic diseases, 6th ed., pp. 143–160, Churchill Livingstone, 1986

  • McEvedy CP, Beard AW. Royal free epidemic of 1955; a reconsideration. British Medical Journal 1: 7–11, 1970

    Article  PubMed  CAS  Google Scholar 

  • McEvedy CP, Beard AW. Concept of benign myalgic encephalomyelitis. British Medical Journal 1: 11–15, 1970

    Article  PubMed  CAS  Google Scholar 

  • Masi AT, Yunus MB. Concepts of illness in populations as applied to fibromyalgia syndrome. American Journal of Medicine 81 (Suppl. 3A): 93–98, 1986

    Google Scholar 

  • Moldofsky H, Scarisbrick P, England R, et al. Musculo-skeletal symptoms and Non-REM sleep disturbance in patients with ‘fibrositis syndrome’ and healthy subjects. Psychosomatic Medicine 37: 341–351, 1975

    PubMed  CAS  Google Scholar 

  • Moldofsky H, Tullis C, Lue FA. Sleep related myoclonus in rheumatic pain modulation disorder (fibrositis syndrome). Journal of Rheumatology 13: 614–617, 1986

    PubMed  CAS  Google Scholar 

  • Molony RR, MacPeek DM, Schiffman PL, et al. Sleep, sleep apnoea and the fibromyalgia syndrome. Journal of Rheumatology 13: 797–800, 1986

    PubMed  CAS  Google Scholar 

  • Payne TC, Leavitt F, Gaison DC, Katz RS, Golden HE, et al. Fibrositis with psychologic disturbance. Arthritis and Rheumatism 25: 213–217, 1982

    Article  PubMed  CAS  Google Scholar 

  • Reynolds MD. The definition of fibrositis. Arthritis and Rheumatism 25: 1506–1507, 1982

    Article  PubMed  CAS  Google Scholar 

  • Richards AJ. Carpal tunnel syndrome and subsequent rheumatoid arthritis in the ‘fibrositis’ syndrome. Annals of the Rheumatic Diseases 43: 232–234, 1984

    Article  PubMed  CAS  Google Scholar 

  • Scudamore C. A treatise on the nature and cure of rheumatism, Longmans, London, 1816

  • Simons DG. Muscle pain syndromes, part I. American Journal of Physical Medicine 54: 289–311,1975

    PubMed  CAS  Google Scholar 

  • Simons DG. Muscle pain syndromes, part II. American Journal of Physical Medicine 55: 15–42, 1976

    PubMed  CAS  Google Scholar 

  • Simons DG. Fibrositis/fibromyalgia: a form of myofascial trigger points? American Journal of Medicine 81 (Suppl. 3A): 93–98, 1986

    Article  PubMed  CAS  Google Scholar 

  • Smythe HA. ‘Fibrositis’ as a disorder of pain modulation. Clinics in Rheumatic Diseases 5: 823–832, 1979

    Google Scholar 

  • Smythe HA. Problems with the MMPI. Journal of Rheumatology 11: 417, 1984

    PubMed  CAS  Google Scholar 

  • Smythe HA. In Kelly et al. (Eds) Textbook of rheumatology, pp. 481–489, WB Saunders & Co., 1985

  • Stockman R. The causes, pathology and treatment of chronic rheumatism. Edinburgh Medical Journal NS 15: 107–116, 222–235, 1904

    Google Scholar 

  • Stockman R. Rheumatism and arthritis, Green, Edinburgh, 1920

  • Straus SE, Tosato G, Armstrong G, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Annals of Internal Medicine 102: 7–16, 1985

    PubMed  CAS  Google Scholar 

  • Szasz TS. The psychiatric perspective on pain and its control. In Hart DF (Ed.) The treatment of chronic pain, pp. 30-61, Medical and Technical Publishing Co. Ltd, London, 1974 Szasz TS. Pain and pleasure, 2nd ed., Basic Books Inc., New York, 1975

  • Trout EF. Fibrositis. Journal of the American Geriatrics Society 16: 531–538, 1968

    Google Scholar 

  • Wolfe F. Development of criteria in the diagnosis of fibrositis. American Journal of Medicine 81 (Suppl. 3A): 99–103, 1986

    Article  PubMed  CAS  Google Scholar 

  • Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. Journal of Rheumatology 10: 965–968, 1983

    PubMed  CAS  Google Scholar 

  • Wolfe F, Cathey MA, Kleinkeksel SM, Amos SP, Hoffman RG, et al. Psychological studies in primary fibrositis and fibrositis associated with rheumatoid arthritis. Journal of Rheumatology 11: 500–506,1984

    PubMed  CAS  Google Scholar 

  • Wysenbeck AJ, Mor F, Lurie Y, Weinberger A. Imipramine for the treatment of fibrositis: a therapeutic trial. Annals of the Rheumatic Diseases 44: 752–753, 1985

    Article  Google Scholar 

  • Yunus MB. Fibromyalgia syndrome: a need for uniform classification. Journal of Rheumatology 10: 841–844, 1983

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hart, F.D. Fibrositis (Fibromyalgia). Drugs 35, 320–327 (1988). https://doi.org/10.2165/00003495-198835030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198835030-00006

Keywords

Navigation